Replies to post #18168 on Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

Blackpantherz, I remember reading about the study done at the Univ of Birmingham. They used dr-70 and several other markers combined for colon cancer.

The result of the study proved that the combination was better than CEA alone but it was NOT a clinically useful test.

If you are attempting to say that the test was useful, I suggest you read the results of the study.

"RESULTS:

Class prediction models based on CEA, DR-70 and sCD26 produced a modest increase in detection accuracy over CEA alone, particularly for early stage cancers. The sensitivity and specificity required for a clinically useful test was not reached."


http://www.ncbi.nlm.nih.gov/pubmed/21263188